KR20030009578A - Oral composition for inhibiting the halitosis - Google Patents

Oral composition for inhibiting the halitosis Download PDF

Info

Publication number
KR20030009578A
KR20030009578A KR1020010039483A KR20010039483A KR20030009578A KR 20030009578 A KR20030009578 A KR 20030009578A KR 1020010039483 A KR1020010039483 A KR 1020010039483A KR 20010039483 A KR20010039483 A KR 20010039483A KR 20030009578 A KR20030009578 A KR 20030009578A
Authority
KR
South Korea
Prior art keywords
green tea
bad breath
weight
composition
extract
Prior art date
Application number
KR1020010039483A
Other languages
Korean (ko)
Other versions
KR100637653B1 (en
Inventor
이병렬
Original Assignee
주식회사 태평양
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 태평양 filed Critical 주식회사 태평양
Priority to KR1020010039483A priority Critical patent/KR100637653B1/en
Publication of KR20030009578A publication Critical patent/KR20030009578A/en
Application granted granted Critical
Publication of KR100637653B1 publication Critical patent/KR100637653B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9767Pinaceae [Pine family], e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A61Q11/02Preparations for deodorising, bleaching or disinfecting dentures

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: An oral composition for inhibiting halitosis including a specified amount of a green tea extract, cetylpyridium chloride and a pine needle extract is provided which has an excellent halitosis removing effect over a long term period. CONSTITUTION: The oral hygiene composition for inhibiting halitosis contains 0.005 to 2.0% by weight of a green tea extract, 0.01 to 5.0% by weight of cetylpyridium chloride and 0.005 to 2.0% by weight of a pine needle extract. For an example, 1kg green tea leave is soaked in 10kg ethanol for 7 days while agitating occasionally, filtered and concentrated under reduced pressure to give 400g concentrate. Also 50g pine needles with a size of 1.0 to 2.0cm are soaked in 500ml mixture of water and ethanol of 1:1 and extracted for 7 days to give a 50mg concentrate. Thereafter, these two extracts are mixed with cetylpyridium chloride and other additives.

Description

구취억제용 구강용 조성물{Oral composition for inhibiting the halitosis}Oral composition for inhibiting bad breath {Oral composition for inhibiting the halitosis}

본 발명은 구취 억제 효과가 우수한 구강용 조성물에 관한 것으로, 더욱 상세하게는 특정함량으로 녹차추출물, 세틸피리디늄 클로라이드 및 솔잎 추출물을 함유하여 구취 억제 효과가 우수한 구강용 조성물에 관한 것이다.The present invention relates to an oral composition having an excellent bad breath inhibitory effect, and more particularly, to a composition for oral cavity having an excellent bad breath inhibitory effect by containing green tea extract, cetylpyridinium chloride and pine needle extract in a specific content.

구취는 타액중에 존재하는 단백질, 음식찌꺼기 등이 구강내에서 미생물에 의해 분해되어 생성된 아미노산이 탈회산 효소나 아미노 효소 등에 의해 분해되어 악취를 유발하는 물질을 생성하므로써 발생된다. 구취를 유발하는 주성분은 휘발성 황화물로 이들 휘발성 화합물에는 황화수소, 메틸머캅탄, 디메틸머캅탄 등이 있으며, 이들 휘발성 황화물이외에 트리에틸아민 등의 휘발성 아민화합물, 알데히드, 지방산, 암모니아 등이 있다.Bad breath occurs when proteins, food residues, etc., present in saliva are decomposed by microorganisms in the oral cavity, and the amino acids produced by decalcification enzymes or amino enzymes are used to produce substances causing odor. The main components that cause bad breath are volatile sulfides, and these volatile compounds include hydrogen sulfide, methyl mercaptan, dimethyl mercaptan, and the like. In addition to these volatile sulfides, volatile amine compounds such as triethylamine, aldehydes, fatty acids, ammonia and the like.

따라서, 구강내에서 발생하는 구취를 억제하기 위해서는 구취의 1차 원인인 구강내 미생물을 제거하거나, 구취를 유발하는 물질을 제거하여야 하는데, 종래에는 녹차의 플라보놀 성분을 함유하는 구취 억제용 구강조성물로부터 알 수 있는 바와 같이, 주로 구취를 유발하는 물질을 제거하여 구취를 억제시켜 왔다.Therefore, in order to suppress bad breath occurring in the oral cavity, it is necessary to remove microorganisms in the oral cavity, which is the primary cause of bad breath, or to remove a substance causing bad breath. In the related art, oral compositions for inhibiting bad breath containing flavonol components of green tea As can be seen, the bad breath has been mainly suppressed by removing the substances causing the bad breath.

그러나, 구취를 유발하는 물질을 제거하는 방법은 단기적으로 구취를 제거할 수는 있지만, 장기간 효과가 지속되지 않는 단점이 있다.However, the method of removing the substance causing bad breath can remove the bad breath in the short term, but there is a disadvantage that the long-term effect does not last.

이에, 본 발명자들은 단기적으로 구취를 억제할 수 있을 뿐만아니라 구취억제 효과가 장기간 유지될 수 있는 구강용 조성물을 개발하고자 연구하였고, 구강용조성물에 구취를 유발하는 물질과 구취의 원인균을 제거할 수 있는 물질을 동시에 함유시키는 경우에 이러한 목적을 달성할 수 있음을 발견하였다.Accordingly, the present inventors have studied to develop a composition for oral cavity that can not only suppress bad breath in the short term but also maintain the bad breath suppression effect for a long time, and can remove the substances causing bad breath and the causative agents of bad breath in the oral composition. It has been found that this object can be achieved by simultaneously containing the substance present.

한편, 종래 이러한 구강내 유해균을 살균하기 위하여 사용된 성분들로는 세틸피리디늄 클로라이드, 염산클로로헥시딘 등이 있는데, 염산클로로헥시딘은 치아 변색을 일으키는 단점이 있고, 세틸피리디늄 클로라이드는 양이온을 띠고 있는 화합물로서 음이온성 물질과의 강한 반응성 때문에 실제 사용시 구강내 환경에 따라 효과가 반감되는 경우가 발생하는 문제점이 있다.On the other hand, conventionally used to sterilize such harmful bacteria in the oral cavity include cetylpyridinium chloride, chlorohexidine hydrochloride, etc. Chlorohexidine hydrochloride has the disadvantage of causing tooth discoloration, cetylpyridinium chloride is a cation As a compound having a strong reactivity with an anionic substance, there is a problem that the effect is sometimes halved depending on the oral environment in actual use.

이에 본 발명자들은 구취의 억제 효과가 우수한 구강용 조성물을 제공하기 위하여 구취 유발 물질 및 구취유발 원인균을 제거할 수 있는 물질을 모두 함유시키면서, 상기한 항균물질이 갖는 문제점을 해결할 수 있는 방법에 대하여 연구를 한 결과, 소취효과가 우수한 녹차추출물과 항균효과가 우수한 세틸피리디늄 클로라이드를 특정한 함량으로 혼합하고, 여기에 세틸피리디늄 클로라이드의 효과를 보완하기 위하여 인체에 안전하고 타성분과의 상용성이 좋으면서 항균효과가 우수한 솔잎추출물을 특정함량으로 더 혼합시킨다면 상기한 목적을 달성할 수 있음을 발견하고 본 발명을 완성하였다.Therefore, the present inventors study on a method for solving the problems of the above-described antimicrobial substances, while containing all the substances that can remove bad breath-causing substances and bad breath-causing bacteria in order to provide a composition for oral cavity excellent in inhibiting bad breath. As a result, green tea extract with excellent deodorant effect and cetylpyridinium chloride with excellent antibacterial effect are mixed in a specific content, and to supplement the effect of cetylpyridinium chloride, it is safe for human body and has good compatibility with other ingredients. It was found that the above object can be achieved by further mixing pine needle extract having excellent antibacterial effect in a specific content and completed the present invention.

상기한 목적을 달성하기 위하여, 본 발명의 구강용 조성물은 녹차 추출물 0.005~2.0중량%, 세틸피리디늄 클로라이드 0.01~5.0중량% 및 솔잎 추출물 0.005~2.0중량%을 함유함을 특징으로 한다.In order to achieve the above object, the composition for oral cavity of the present invention is characterized in that it contains 0.005 ~ 2.0% by weight green tea extract, 0.01 ~ 5.0% by weight cetylpyridinium chloride and 0.005 ~ 2.0% by weight pine needle extract.

이하, 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명의 구강용 조성물은 녹차 추출물에 의한 소취 효과로 사용직후의 구취제거 효과와 함께 항균제로서 세틸피리디늄 클로라이드를 함유하여 구취유발 원인균을 제거하면서 동시에 솔잎 추출물을 함유하여 세틸피리디늄 클로라이드가 구강 환경에 따라 효과가 저하되는 문제를 해결하였다.The composition for oral cavity of the present invention is a deodorant effect by the green tea extract, with ceftylpyridinium chloride as an antimicrobial agent with the effect of eliminating bad breath immediately after use, while removing the causative agents causing bad breath, while at the same time containing cetylpyridinium chloride oral environment This solves the problem that the effect is lowered.

먼저, 본 발명의 구강용 조성물에 함유되는 각각의 성분들에 대해서 살펴보면 다음과 같다.First, looking at each of the components contained in the composition for oral cavity of the present invention are as follows.

(1) 녹차 추출물(1) green tea extract

녹차 추출물은 차잎 중의 유효성분을 분리, 정제한 것으로 치약, 구취 제거용품, 소취제, 화장품 등의 일상 생활용품에 다양하게 이용되고 있다. 특히, 녹차에 함유되어 있는 성분중 플라보놀 성분이 구강내 악취성분에 대하여 강한 소취효과를 나타내는 것이 여러 가지 실험을 통해 입증되고 있다.Green tea extract is a separation and purification of the active ingredient in tea leaves and is used in a variety of daily necessities such as toothpaste, deodorant, deodorant, cosmetics. In particular, it has been demonstrated through various experiments that the flavonol component of green tea exhibits a strong deodorant effect on oral odor components.

본 발명 또한 녹차 추출물의 이러한 소취효과를 이용한 것이다.The present invention also utilizes this deodorant effect of green tea extract.

녹차 추출물의 제조방법은 식물로부터 유효성분을 추출하는 통상의 방법에 따라 제조할 수 있으며, 예를 들면 차잎을 잘게 절단한 것을 물 또는 극성 유기용매 단독 또는 이들의 혼합물에 침지하여 추출물을 얻은 후, 여과하고 여액을 감압농축하는 방법에 의해 제조할 수 있다.The method for preparing green tea extract may be prepared according to a conventional method of extracting an active ingredient from a plant. For example, a finely cut tea leaf is immersed in water or a polar organic solvent alone or a mixture thereof to obtain an extract. It can manufacture by the method of filtering and concentrating a filtrate under reduced pressure.

본 발명의 구강용 조성물은 이 녹차 추출물을 조성물 총 중량에 대하여 0.005~2.0중량%의 양으로 함유한다. 이는 일반적으로 녹차추출물의 함량을 증가시키면 조성물의 구취 제거 효과는 상승하지만 조성물의 경시 안정성이 떨어지므로, 2.0중량%를 초과하는 농도에서는 실온에서 보관시에 갈변현상이 발생하는 등 제품으로서의 가치가 하락하는 문제점이 있고, 0.005중량% 미만에서는 구취제거 효과를 얻을 수가 없기 때문이다.The composition for oral cavity of this invention contains this green tea extract in the quantity of 0.005 to 2.0 weight% with respect to the composition total weight. Generally, increasing the content of green tea extract increases the bad breath removal effect of the composition, but the stability of the composition decreases with time, and the value of the product decreases, such as browning phenomenon when stored at room temperature at a concentration exceeding 2.0% by weight. This is because there is a problem, and if less than 0.005% by weight, bad breath removal effect cannot be obtained.

(2) 세틸피리디늄 클로라이드(2) cetylpyridinium chloride

세틸피리디늄 클로라이드(Cetylpyridinium Chloride: C21H38ClN·H2O : 358.01)는 양이온성 암모늄염 항균제의 하나로 구강내 유해균을 살균하므로써, 치면 세균막의 형성을 막아 프라그를 억제하고 치은염, 치주염을 비롯한 각종 잇몸질환에 탁월한 효과를 나타내어 구강제품에 많이 사용되고 있는 성분이다. 또한, 적절한 낮은 농도에서 사용되는 경우에 안전하다고 밝히고 있으며, 주로 마우스워시와 같은 구강위생용품에서 안전하게 사용되고 있다.Cetylpyridinium Chloride (C 21 H 38 ClN · H 2 O: 358.01) is a cationic ammonium salt antibacterial agent that sterilizes harmful bacteria in the oral cavity. It has excellent effect on gum disease and is widely used in oral products. In addition, it is said to be safe when used at a suitable low concentration, and is mainly used safely in oral hygiene products such as mouse wash.

세틸피리디늄 클로라이드는 구강내의 각종질환을 일으키는 혐기성세균과 호기성세균에 대해 살균력과 발육억제력을 나타내며, 칸디다 알비칸스(Candida albicans)를 포함한 곰팡이에 대해서도 활성을 지닌 것으로 알려져 있다. 밝혀진 메카니즘으로는 세포벽에 흡착해서 박테리아의 대사작용을 방해하고, 박테리아의 성장을 억제하여 결국에는 박테리아를 파괴한다. 생체 실험에서는S. mutansS. sanguis등에 대한 작용이 밝혀져 있으며, 세틸피리디늄 클로라이드를 함유한 구강제품은 치은연상 프라그의 축적을 감소시킬 수 있고, 치주질환에 관계하는 세균에 효과를 나타냄으로써 치은염의 정도를 경감시키는 효과가 있다(Oral Hygiene Products and Practice, p333-338).Cetylpyridinium chloride exhibits bactericidal and growth inhibitory activity against anaerobic and aerobic bacteria causing various diseases in the oral cavity, and is known to be active against fungi including Candida albicans . The mechanisms identified are adsorption to cell walls, disrupting the metabolism of bacteria, inhibiting their growth and eventually destroying bacteria. In vivo experiments have revealed the effects on S. mutans and S. sanguis, and oral products containing cetylpyridinium chloride can reduce the accumulation of plaque-associated plaques and have effects on bacteria associated with periodontal disease. It has the effect of alleviating the degree of (Oral Hygiene Products and Practice, p333-338).

본 발명의 조성물은 이러한 효과가 있는 세틸피리디늄 클로라이드를 조성물 총 중량에 대하여 0.01~5.0중량%의 양으로 함유한다. 이는 세틸피리디늄 클로라이드는 원료 자체에서 특유의 쓴맛이 있기 때문에 5.0중량%를 초과하는 경우에는 조성물의 쓴맛이 너무 강해서 사용하기 어렵게 되는 문제점이 있고, 0.01중량% 미만에서는 항균효과가 거의 없기 때문이다.The composition of the present invention contains cetylpyridinium chloride having such an effect in an amount of 0.01 to 5.0% by weight based on the total weight of the composition. This is because cetylpyridinium chloride has a bitter taste peculiar to the raw material itself, so if the content exceeds 5.0% by weight, the bitter taste of the composition is too strong to be difficult to use, and less than 0.01% by weight of the antibacterial effect.

(3) 솔잎추출물(3) pine needle extract

소나무는 파이너스(Pinus)속으로 세계에 약 80-90종이 있으며 이들에서 채취한 테르펜 등이 주로 산업에 이용되고 있다. 솔잎의 주요성분은 터펜틴 오일(Terpenetine oil), 시네올(Cineole), 살리니그린(Salinigrin), 코니페린(Coniferin), 피-사이멘(P-Cymen), 덴시피마릭산(Densipimaric acid), 레텐(Retene)등과 엽록소, 단백질, 조지방, 인, 철분, 효소, 미네랄, 지용성 비타민 A및 비타민 C 등도 함유되어 있으며, 이들성분들은 소나무의 종과 채취한 계절에 따라서 다소 차이가 있다.Pine is a genus of about 80-90 species in the world, and the terpenes collected from them are mainly used in industry. The main components of pine needles are Terpennetine oil, Cineole, Salinigrin, Coniferin, P-Cymen, Densipimaric acid, Retene, chlorophyll, protein, crude fat, phosphorus, iron, enzymes, minerals, fat-soluble vitamin A and vitamin C, etc., and these components vary slightly depending on the species of pine and the season harvested.

종래 솔잎은 경험의학적으로 각종 약효가 발휘된다고 알려져 민간요법으로 사용되어져 왔다. 그 중에 구강질환에 관련하여, 구취에는 솔잎을 물에 씻어 몇 개를 씹는다고 하였고, 구내염에는 송엽액을 탈지면에 묻혀 환부에 바른다고 하였다. 그밖에 치통에는 솔잎을 끓인 물로 양치질을 하고, 잇몸이 부은데는 솔잎 졸인 것에 소금을 넣어 입에 한참 물고 있고, 아구창에는 솔잎을 한 줌 달여서 그 즙을 입안에 물었다가 양치질을 하며, 치조농루에는 솔잎 졸인 물로 양치질을 하면 효과가 있다고 하였다(솔잎건강법, pp. 56-147).Conventional pine needles have been used for folk remedies known empirically and various effects. Among those related to oral disease, bad breath was used to chew a few pine needles in water, and for stomatitis, pineal fluid was applied to cotton wool and applied to affected areas. In addition, the toothache is brushed with boiled water, the gums are swollen, and the salt is added to the boiled pine needles. Salt is put in the mouth for a while, and the thrush is given a handful of pine needles and the juice is bitten in the mouth. Brushing teeth with water is effective (pine needle health method, pp. 56-147).

본 발명의 조성물은 이와 같이 종래 구강질환의 치료에 사용되었던 솔잎 추출물을 함유하므로 세틸피리디늄 클로라이드가 구강내의 환경에 의해 구취유발균에 대한 항균효과가 저하되는 것을 방지하여 효과적으로 구취를 억제할 수 있다.Since the composition of the present invention contains a pine needle extract that has been used in the conventional treatment of oral diseases, cetylpyridinium chloride can effectively inhibit bad breath by preventing the antibacterial effect of bad breath-causing bacteria caused by the oral environment. .

솔잎 추출물의 제조방법은 식물로부터 유효성분을 추출하는 통상의 방법에 따라 제조할 수 있으며, 예를 들면 솔잎을 잘게 절단한 것을 물 또는 극성 유기용매 단독 또는 이들의 혼합물에 침지하여 추출물을 얻은 후 여과하고 여액을 감압농축하는 방법에 의해 제조할 수 있다.The preparation method of pine needle extract can be prepared according to a conventional method of extracting the active ingredient from the plant, for example, finely cut pine needles are immersed in water or a polar organic solvent alone or a mixture thereof to obtain the extract and then filtered. And the filtrate is concentrated under reduced pressure.

본 발명의 조성물은 상기한 솔잎 추출액을 조성물 총 중량에 대하여 조성물 총 중량에 대하여 0.005~2.0중량%의 양으로 함유한다. 이는 0.005중량% 미만으로 배합되는 경우에는 구취유발균에 대한 항균 효과가 나타나지 않으며, 2.0중량%를 초과하는 경우에는 떫은 맛과 특이한 냄새 등이 강해 사용하기에 곤란하기 때문이다.The composition of the present invention contains the pine needle extract in an amount of 0.005 to 2.0% by weight based on the total weight of the composition with respect to the total weight of the composition. This is because when it is formulated at less than 0.005% by weight, there is no antimicrobial effect against bad breath-causing bacteria, and when it exceeds 2.0% by weight, it is difficult to use because of its strong taste and peculiar smell.

본 발명의 구강용 조성물의 제형은 특별히 한정되지 않지만, 치약, 구강청정제 등의 구강 위생증진제의 여러 제형으로 제조될 수 있으며, 본 발명에서는 구강청정제로 실험하였다.The formulation of the composition for oral cavity of the present invention is not particularly limited, but may be prepared in various formulations of oral hygiene enhancers such as toothpaste and mouthwashes, and in the present invention, experiments with mouthwashes.

본 발명의 구강청정제 조성물은 상기한 성분들 이외에 추가로 습윤제, 감미제, pH조정제, 방부제, 착색제, 수렴제, 충치예방제 및 약용성분, 기포제 및 가용화제, 향료, 용제 등을 함유할 수 있다.In addition to the above components, the mouthwash composition of the present invention may further contain a humectant, a sweetener, a pH adjuster, a preservative, a colorant, an astringent, a caries preventive agent and a medicinal ingredient, a foaming agent and a solubilizer, a perfume, a solvent, and the like.

습윤제로는 글리세린, 소르비톨액, 폴리에틸렌글리콜, 프로필렌글리콜 등이 있고, 감미제로는 삭카린나트륨, 아스파탐, 스테비오사이드, 감초산 등이 있으며 pH조정제로는 인산나트륨, 인산이나트륨, 인산삼나트륨, 피로인산나트륨, 구연산, 구연산나트륨, 주석산 등이 있고 방부제로는 파라옥시안식향산메칠, 파라옥시안식향산프로필, 안식향산나트륨 등이 있다.Wetting agents include glycerin, sorbitol solution, polyethylene glycol, and propylene glycol.Sweeping agents include saccharin sodium, aspartame, stevioside, and licoriceic acid. Sodium phosphate, citric acid, sodium citrate, tartaric acid and the like, and preservatives include methyl paraoxybenzoate, propyl paraoxybenzoate, sodium benzoate.

수렴제로는 염화아연이 사용되며, 충치예방제로는 불화나트륨, 일불소인산나트륨, 불화주석, 유기불소화합물이 있으며, 약용성분으로는 알란토인클로로히드록시알루미네이트, 아미노카프론산, 초산토코페롤, 염산피리독신 등을 단독 또는 2종 이상을 혼합하여 사용할 수 있다.Zinc chloride is used as astringent, and caries preventive agents include sodium fluoride, sodium monofluorophosphate, tin fluoride, and organic fluorine compounds. Etc. can be used individually or in mixture of 2 or more types.

또한, 기포제 또는 가용화제로는 자당지방산 에스테르, 폴리옥시에틸렌 경화피마자유, 소르비탄 지방산 에스테르, 폴리옥시에틸렌 폴리옥시프로필렌 코폴리머 등의 비이온 계면활성제를 단독 또는 2종 이상 혼합하여 사용한다.As the foaming agent or solubilizer, nonionic surfactants such as sucrose fatty acid ester, polyoxyethylene hardened castor oil, sorbitan fatty acid ester, and polyoxyethylene polyoxypropylene copolymer are used alone or in combination of two or more thereof.

향료로는 페퍼민트오일, 스페아민트오일, 멘톨, 카르본, 아네톨 등을 단독 또는 혼합 사용하며, 용제로는 에탄올, 정제수를 배합하고 기타 식용색소를 착색제로 사용한다.As the fragrance, peppermint oil, spearmint oil, menthol, carbon, and anetol may be used alone or in a mixture. As a solvent, ethanol, purified water may be used, and other food coloring may be used as a colorant.

이하, 실시예 및 시험예를 들어 본 발명을 상세히 설명하지만, 본 발명이 이들예로만 한정되는 것은 아니다.Hereinafter, although an Example and a test example are given and this invention is demonstrated in detail, this invention is not limited only to these examples.

<참조예 1> 녹차 추출물의 제조Reference Example 1 Preparation of Green Tea Extract

녹차잎 1kg에 70% 에탄올 10kg을 넣어 가끔 교반하면서 실온에서 7일간 침적한 후, 여과하고, 얻어진 여액을 감압 농축하여 농축물 400g를 얻었다.10 kg of 70% ethanol was added to 1 kg of green tea leaves, and the mixture was immersed at room temperature for 7 days with occasional stirring. The resulting filtrate was concentrated under reduced pressure to obtain 400 g of concentrate.

<참조예 2> 솔잎 추출물의 제조Reference Example 2 Preparation of Pine Needle Extract

채취한 솔잎을 1.0~2.0㎝ 크기로 절단한 것 50g에 물과 에탄올의 1:1 혼합 액을 500㎖의 비율로 가하여 실온에서 7일간 침적하여 추출, 여과한 후, 그 여과액을 감압 농축하여 농축물 50㎎을 얻었다.50 g of collected pine needles were cut into 1.0-2.0 cm in size, and a 1: 1 mixed solution of water and ethanol was added at a rate of 500 ml. The mixture was immersed and extracted for 7 days at room temperature, and the filtrate was concentrated under reduced pressure. 50 mg of concentrate was obtained.

<실시예 1 및 비교예 1~4><Example 1 and Comparative Examples 1-4>

성분ingredient 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 비교예 4Comparative Example 4 실시예 1Example 1 중량%weight% 불화나트륨Sodium fluoride 0.300.30 0.300.30 0.300.30 0.300.30 0.300.30 세틸피리디늄클로라이드Cetylpyridinium chloride -- 0.050.05 0.050.05 -- 0.050.05 솔잎추출물(참고예 2)Pine needle extract (Reference Example 2) 0.100.10 -- 0.100.10 -- 0.100.10 녹차추출물(참고예 1)Green Tea Extract (Reference Example 1) -- -- -- -- 0.100.10 농글리세린Concentrated glycerin 3.003.00 3.003.00 3.003.00 3.003.00 3.003.00 소르비톨액Sorbitol solution 10.0010.00 10.0010.00 10.0010.00 10.0010.00 10.0010.00 폴리옥시에틸렌경화피마자유Polyoxyethylene Cured Castor Oil 1.001.00 1.001.00 1.001.00 1.001.00 1.001.00 삭카린나트륨Zaccarin Sodium 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 나트륨벤조에이트Sodium benzoate 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 시트르산Citric acid 0.030.03 0.030.03 0.030.03 0.030.03 0.030.03 향료Spices 0.200.20 0.200.20 0.200.20 0.200.20 0.200.20 엘멘톨Elmenthol 0.200.20 0.200.20 0.200.20 0.200.20 0.200.20 정제수Purified water to 100to 100 to 100to 100 to 100to 100 to 100to 100 to 100to 100

<시험예 1> 항균력 비교시험Test Example 1 Comparative Test

실시예 1과 비교예 1~4를 1:20에서 1:5120까지 희석한 시험액 2㎖와 혈액 한천 배지(혈액 한천 베이스 + 최종 농도 5%의 양 혈액) 18㎖를 9cm 페트리 디쉬(petri dish)에 부었다. 그 후 시험균을 접종하고, 혐기성 챔버를 이용하여 37℃에서 96시간 동안 배양하였다. 시험균이 자라지 않는 최대희석비율을 MID로 측정하여 그 결과를 표 1에 나타내었다(Bactron I. anaerobic chamber를 사용).2 ml of test solution diluted from Example 1 and Comparative Examples 1-4 from 1:20 to 1: 5120 and 18 ml of blood agar medium (blood agar base + final blood 5% sheep) were 9 cm petri dishes. Poured into. The test bacteria were then inoculated and incubated at 37 ° C. for 96 hours using an anaerobic chamber. The maximum dilution rate at which the test bacteria did not grow was measured by MID, and the results are shown in Table 1 (using the Bactron I. anaerobic chamber).

시험균은 구취원인균인후소박테리움 누클레아툼(Fusobacterium nucleatum)ATCC 25586과폴피로모나스 긴기발리스(Porphyromonas gingivalis)ATCC 33277를 사용하였다.The test bacteria were Fusocacterium nucleatum ATCC 25586 and Porphyromonas gingivalis ATCC 33277.

시험균Test bacteria 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 비교예 4Comparative Example 4 실시예 1Example 1 후소박테리움 누클레아툼Husobacterium Nucleatum (Fusobacterium nucleatum)(Fusobacterium nucleatum) 320320 640640 25602560 >20> 20 25602560 폴필로모나스 긴기발리스Polfimonas Gingalis (Porphyromonas gingivalis)(Porphyromonas gingivalis) 160160 320320 12801280 >20> 20 25602560

[시험예 2] 타액내 세균수 측정Test Example 2 Measurement of the Number of Bacteria in Saliva

15㎖ Falcon 튜브에 멸균된 0.1% 펩톤용액(0.9% NaCl 1000㎖ 에 peptone 1g을 첨가)을 5㎖씩 분주하여 40개를 준비한 후, 실험 대상자 40명에게 펩톤용액을 15초간 수구하게 하고, 이 펩톤용액을 멸균된 0.067M 인산염 완충용액(pH 7.2)으로 10배 희석하였다. 희석한 이 용액 100㎕를 취하여 Mitis Salivarius Agar 에 분주하고, 멸균된 bending glass로 평판에 전체적으로 도말한 다음, 37℃ 배양기에 12시간 배양하고 혐기성 챔버에서 37℃의 온도로 48시간동안 다시 배양한 후, 콜로니 계수기(Colony counter)를 이용해 각 배지에서Streptococcus mutans의 콜로니를 측정하여 기록하였다.Streptococcus mutans의 콜로니는 현미경적 검사를 통하여 균의 종류를 확인하고, 표준균주Streptococcus mutansNTCC 10449를 MSA에 같은 시간과 조건으로 배양한 후 콜로니의 형태를 확인하여, 실험대상자에서Streptococcus mutans의 콜로니만을 선별하여 측정하였다. 실험 대상자 한사람 당, 희석된 펩톤수구액을 Mitis Salivarius Agar 평판 2개에 분주하여, 콜로니 측정을 1차, 2차 2회에 걸쳐 시행하여 두 측정의 평균값을 실험대상자의스트렙토코커스무탄스(Streptococcus mutans)수로 하였다.After dispensing 5 ml of sterilized 0.1% peptone solution (add 1 g of peptone to 1000 ml of 0.9% NaCl) in a 15 ml Falcon tube, 40 were prepared, and 40 subjects received water for 15 seconds. The peptone solution was diluted 10-fold with sterile 0.067 M phosphate buffer (pH 7.2). Take 100 μl of this diluted solution and dispense to Mitis Salivarius Agar, spread it on a plate with sterile bending glass, and then incubate for 12 hours in a 37 ° C incubator and incubate for 48 hours at 37 ° C in an anaerobic chamber. The colony of Streptococcus mutans in each medium was measured and recorded using a colony counter. The colonies of Streptococcus mutans were identified by microscopic examination, and the colonies of Streptococcus mutans were selected from the subjects by incubating the standard strain Streptococcus mutans NTCC 10449 in MSA at the same time and conditions. It was measured by. Diluted peptone water poloxial solution was dispensed to two plates of Mitis Salivarius Agar per test subject, and colony measurements were performed twice and two times, and the average value of the two measurements was determined by streptococcus mutans. ) Number .

경과시간Elapsed time 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 비교예 4Comparative Example 4 실시예 1Example 1 실험직후Right after the experiment 104104 103103 102102 105105 104104 2주 후after 2 weeks 6666 4545 2424 9595 2222

표 2의 결과로부터 알 수 있는 바와 같이, 솔잎추출물과 세틸피리디늄 클로라이드를 전혀 함유하지 않은 비교예 4의 조성물은Streptococcus mutans의 수가 거의 줄어들지 않았다. 그러나, 세틸피리디늄 클로라이드를 함유한 비교예 2의 경우에는 시험예 1에서와는 달리 솔잎추출물을 함유한 비교예 1에 비하여 높은 수취를 나타내었다. 이것은 세틸피리디늄 클로라이드가 실제 사용시 구강내 환경에 의해 영향을 받는다는 것을 암시한다. 반면에, 세틸피리디늄 클로라이드와 솔잎추출물이 병용된 비교예 3의 경우에는 탁월한 결과를 나타내었다. 이것으로부터 구강 환경에 따른 세틸피리디늄 클로라이드의 항균효과 저하를 솔잎추출물이 보완을 한다는 것을 알 수 있다.As can be seen from the results of Table 2, the composition of Comparative Example 4 containing no pine needle extract and cetylpyridinium chloride did not reduce the number of Streptococcus mutans almost. However, in the case of Comparative Example 2 containing cetylpyridinium chloride, unlike in Test Example 1, it showed a higher reception compared to Comparative Example 1 containing a pine needle extract. This suggests that cetylpyridinium chloride is affected by the oral environment in practical use. On the other hand, in the case of Comparative Example 3 in which cetylpyridinium chloride and pine needle extract is used together, excellent results were obtained. From this, it can be seen that pine needle extract supplements the antibacterial effect of cetylpyridinium chloride according to the oral environment.

[시험예 3] 소취효과측정Test Example 3 Deodorization Effect Measurement

실험대상자 30명에게 0.5mg의 마늘을 저작하게 하여, 실험대상자의 구강에서 구취가 발생하도록 한 다음, 양치전과 양치후에 호기중의 구취성분인 메칠머캅탄과 알릴머캅탄의 양을 측정하여, 양치전후의 구취감소율을 산출하였다.Thirty subjects were allowed to chew 0.5 mg of garlic to cause bad breath in the oral cavity of the subjects. The rate of bad breath before and after was calculated.

마늘을 저작시킨 시간은 2분이었고, 양치후 5분, 10분, 15분, 30분에 각각 메칠머캅탄과 알릴머캅탄의 양을 측정 비교하여, 양치후 경과시간별 구취감소율을 산출하였다.The garlic chewing time was 2 minutes, and the amounts of methylmercaptan and allylmercaptan were measured and compared at 5, 10, 15, and 30 minutes after brushing, respectively.

구강으로부터의 호기는 기체흡입사출기의 선단을 구강에 삽입하고, 10㎖의 호기를 채취하였다. 호기중의 메틸머캅탄과 알릴머캅탄만을 분석하기 위해, 기체크로마토그래피(HP5890)에 2.0㎖용 시료수집관(Sampling loop)를 부착하였다. 검출기는 FPD(Flame Photometric Detetector)를 사용하였으며, 컬롬은 Chromosil 3-00(Supelco)을 충전한 길이가 6ft이고 외경이 1/8 인치인 테플론관을 이용하였다. 컬럼의 온도는 70℃, 운반 기체는 헬륨을 20㎖/min의 조건으로 하였다.The exhalation from the oral cavity was inserted into the oral cavity with the tip of the gas suction injection machine, and 10 ml of exhalation was collected. In order to analyze only methylmercaptan and allylmercaptan in expiratory air, a 2.0 ml sampling loop was attached to gas chromatography (HP5890). The detector was a FPD (Flame Photometric Detetector), and the colum was a Teflon tube filled with Chromosil 3-00 (Supelco) 6 ft long and 1/8 inch outside diameter. The column temperature was 70 ° C. and the carrier gas was helium at 20 mL / min.

메틸머캅탄양 감소율(%)Methylmercaptan amount reduction rate (%) 마늘저작후 경과시간Elapsed time after garlic 비교예 3Comparative Example 3 실시예 1Example 1 5분5 minutes 58.458.4 85.485.4 10분10 minutes 65.265.2 88.088.0 15분15 minutes 77.577.5 91.591.5 30분30 minutes 80.180.1 95.695.6

알릴머캅탄양 감소율(%)Allyl mercaptan amount reduction rate (%) 마늘저작후 경과시간Elapsed time after garlic 비교예 3Comparative Example 3 실시예 1Example 1 5분5 minutes 53.953.9 86.586.5 10분10 minutes 70.070.0 89.989.9 15분15 minutes 73.973.9 93.593.5 30분30 minutes 76.876.8 96.396.3

표 3 및 표 4에서 알 수 있듯이, 솔잎추출물과 세틸피리디늄 클로라이드 외에 녹차추출물을 함유한 실시예 1이 녹차추출물을 함유하지 않은 비교예 3에 비하여 마늘저작후의 메틸머캅탄과 알릴머캅탄양의 감소율이 더 높았다. 따라서, 녹차추출물의 뛰어난 소취 효과에 의해 구취제거 효과가 상승함을 확인하였다.As can be seen from Table 3 and Table 4, the reduction rate of the amount of methyl mercaptan and allyl mercaptan after garlic operation compared to Comparative Example 3 in which Example 1 containing green tea extract in addition to pine needle extract and cetylpyridinium chloride did not contain green tea extract This was higher. Therefore, it was confirmed that the deodorizing effect is increased by the excellent deodorizing effect of green tea extract.

[시험예 4] 구취제거 효과측정Test Example 4 Measurement of Bad Breath Removal Effect

실험대상자 80명에게 48시간동안 일체의 구강환경관리를 중지시킨 후, 할리메타로 구취정도를 측정하고 나서 평균수치가 비슷하도록 8군으로 나눈다. 각각의 군에 대하여 실시예 1과 비교예 1~4 시험 양치액으로 양치하게 하였다. 양치후 30분 경과시점에 다시 구취정도를 측정하였다. 이어서 28일간 각각의 시험양치액을 1일 2회씩 사용하도록 하였다. 7일, 14일, 21일 및 28일에 소환하여, 양치후 30분 경과시점에 다시 구취정도를 측정하여, 그 결과를 표 5에 나타내었다.After 80 hours of treatment, all oral environment management was stopped for 48 hours. After measuring bad breath with a harimeta, the test was divided into 8 groups so that the average value was similar. Each group was allowed to brush with Test Example 1 and Comparative Example 1-4. At 30 minutes after brushing, the degree of bad breath was measured again. Each test fern was then used twice a day for 28 days. Summoned at 7 days, 14 days, 21 days and 28 days, the degree of bad breath was measured again 30 minutes after brushing the teeth, and the results are shown in Table 5.

경과시간Elapsed time 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 비교예 4Comparative Example 4 실시예 1Example 1 실험직후Right after the experiment 220220 225225 218218 221221 170170 7일7 days 204204 210210 171171 224224 112112 14일14 days 195195 197197 142142 220220 8383 21일21st 183183 188188 112112 218218 7171 28일28 days 172172 176176 105105 219219 5252

표 5는 구강청정제 조성물의 사용기간에 따른 구취감소효과를 나타낸 것으로서, 녹차추출물, 세틸피리디늄 클로라이드 및 솔잎 추출물을 혼용한 실시예 1의 조성물의 구취점수는 현저하게 감소되었다.Table 5 shows the bad breath reduction effect according to the use period of the mouthwash composition, the bad breath score of the composition of Example 1 was mixed with green tea extract, cetylpyridinium chloride and pine needle extract was significantly reduced.

상기에서 설명한 바와 같이, 본 발명에 따른 구강용 조성물은 장기간에 걸쳐 우수한 구취제거 효과를 제공할 수 있다.As described above, the composition for oral cavity according to the present invention can provide an excellent bad breath removing effect over a long period of time.

Claims (1)

녹차 추출물 0.005~2.0중량%, 세틸피리디늄 클로라이드 0.01~5.0중량% 및 솔잎 추출물 0.005~2.0중량%를 함유하는 것을 특징으로 하는 구취 억제용 구강용 조성물.Oral composition for inhibiting bad breath, characterized in that it contains green tea extract 0.005 ~ 2.0% by weight, cetylpyridinium chloride 0.01 ~ 5.0% by weight and pine needle extract 0.005 ~ 2.0% by weight.
KR1020010039483A 2001-07-03 2001-07-03 Oral composition for inhibiting the halitosis KR100637653B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010039483A KR100637653B1 (en) 2001-07-03 2001-07-03 Oral composition for inhibiting the halitosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010039483A KR100637653B1 (en) 2001-07-03 2001-07-03 Oral composition for inhibiting the halitosis

Publications (2)

Publication Number Publication Date
KR20030009578A true KR20030009578A (en) 2003-02-05
KR100637653B1 KR100637653B1 (en) 2006-10-24

Family

ID=27713169

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010039483A KR100637653B1 (en) 2001-07-03 2001-07-03 Oral composition for inhibiting the halitosis

Country Status (1)

Country Link
KR (1) KR100637653B1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007180A1 (en) * 2003-07-16 2005-01-27 Ajou Medics Co.,Ltd A composition for the improvement of the smell of the armpit
KR100951396B1 (en) * 2003-03-17 2010-04-07 동아제약주식회사 Dental composition for antiplaque and antigingivity
KR101337891B1 (en) * 2006-11-30 2013-12-09 (주)아모레퍼시픽 Oral composition for sol-gel phase transition containing a thermo-sensitive polymer
KR20160047223A (en) * 2014-10-22 2016-05-02 (주)아모레퍼시픽 Oral composition
KR20180036296A (en) * 2016-09-30 2018-04-09 노영수 Method for preparing surfactant-free gagle for oral hygiene using pine tree extract
WO2020096299A1 (en) * 2018-11-05 2020-05-14 (주)아모레퍼시픽 Green tea extract having modified constituent content and composition comprising same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102313830B1 (en) 2019-10-01 2021-10-18 김성윤 Composition for inhibiting halitosis containing seaweed extracts

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100951396B1 (en) * 2003-03-17 2010-04-07 동아제약주식회사 Dental composition for antiplaque and antigingivity
WO2005007180A1 (en) * 2003-07-16 2005-01-27 Ajou Medics Co.,Ltd A composition for the improvement of the smell of the armpit
US7749548B2 (en) 2003-07-16 2010-07-06 Ajou Medics Co., Ltd. Composite for the improvement of the smell of the armpit
KR101337891B1 (en) * 2006-11-30 2013-12-09 (주)아모레퍼시픽 Oral composition for sol-gel phase transition containing a thermo-sensitive polymer
KR20160047223A (en) * 2014-10-22 2016-05-02 (주)아모레퍼시픽 Oral composition
KR20180036296A (en) * 2016-09-30 2018-04-09 노영수 Method for preparing surfactant-free gagle for oral hygiene using pine tree extract
WO2020096299A1 (en) * 2018-11-05 2020-05-14 (주)아모레퍼시픽 Green tea extract having modified constituent content and composition comprising same

Also Published As

Publication number Publication date
KR100637653B1 (en) 2006-10-24

Similar Documents

Publication Publication Date Title
US9532939B2 (en) Combinations for oral compositions, their preparation and use
KR101480690B1 (en) Oral composition containing natural agent
KR100637653B1 (en) Oral composition for inhibiting the halitosis
KR19980013946A (en) Oral composition of liquid type
KR20180081032A (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
KR100450391B1 (en) Toothpaste Composition
KR101881636B1 (en) Composition for prevention or treatment of oral disease comprising Pueraria Extract
KR101703269B1 (en) Oral care composition comprising Magnolia officinalis extract and bicarbonate
KR20170037230A (en) Oral composition comprising cassava extract
JP3009531B2 (en) Periodontal disease prevention agent
KR102597684B1 (en) Oral composition comprising amaranth extract
KR20030089047A (en) Composition for enhancing oral health
RU2312657C2 (en) Mouth cavity rinsing agent
JP2003012483A (en) Composition for oral cavity application
KR20170142740A (en) Composition for treating or preventing oral diseases comprising natural complex
KR20140055885A (en) The gargle composites for the increment of the oral care
KR101816638B1 (en) Oral composition comprising saponin extracted from the root of Camellia sinensis
KR20020082308A (en) Composition for the mouth containing extraction of Euonymus alatus Sieb
KR102283663B1 (en) Antimicrobial composition comprising extracts of herb
KR20120112929A (en) Oral composition comprising rhus verniciflua extracts and hinokitiol
KR20170103482A (en) Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract
KR100659139B1 (en) Oral composition having a good antibacterial effect
KR20170103494A (en) Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract
KR101818211B1 (en) Composition for prevention or treatment of oral disease comprising Arctill fructus Extract
KR20240078208A (en) Composition for teeth whitening and antibacterial for oral microorganisms comprising apple extract

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120918

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20130910

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20150914

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20161010

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20170928

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20181002

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20190926

Year of fee payment: 14